Results: Patients who belong to high risk comprised about 31.9%, medium risk 26.9% and low risk at 41.2%. There were about 32.6% of the patients with low risk had an infectious outcome. Among the medium risk, more patients (70.7%) had an infectious outcome. Further, medium risk patients were 7.4 times more likely to have an infectious outcome as compared to low risk (OR = 7.4). The relationship was significant (P-value = 0.000). There were about 32.6% of the low-risk patients with infectious outcomes while about 78.3% of the patients with high risk have infectious outcomes. Those with high risk are 5.0 times more likely to have an infectious outcome as compared to low risk (OR = 5.0). The relationship was significant (P-value = 0.000).
outcomes. Those with high risk are 5.0 times more likely to have an infectious outcome as compared to low risk (OR = 5.0). The relationship was significant (P-value = 0.000).
Conclusion:
The relationship between risk stratification (Medium risk vs Low risk) and type of pulmonary out-patient (infectious vs non-infectious) is significant. The relationship between risk stratification (High risk vs Low risk) and type of pulmonary out-patient (infectious s non-infectious) is significant. The Second Hospital of JiLin University, China
Background and Aims: The aim of the study is to evaluate the efficacy and safety of glucocorticoid in the treatment of severe community acquired pneumonia via meta-analysis.
Methods: Several databases including Chinese and English database such as PubMed, EMBASE, Cochrane Library, EBASO, Medline, Google Scholar, Science Dicet, CBM, CNKI and so on were searched for related studies published in English or Chinese up to January, 2018. Randomized controlled trials (RCTs) of corticosteroids in hospitalized adults with severe CAP were included. The inclusion and exclusion criteria were used to screen the literature which fulfil the requirement. In addition, we brought the Jadad scale into play to evaluate the quality of the inclusion literature, and extracte data by means of the Cochrane system evaluation manual. Meta-analysis was performed by a random-effect model with RevMan 5.3 software.
Results: We included 10 RCTs enrolling 665 severe CAP patients.
Compared with conventional treatment, adjunctive corticosteroids significantly reduced all-cause mortality (OR = 0.38, 95%CI:0.22-0.65, Z = 3.46, P = 0.005(<0.05)). In subgroup analysis by duration of corticosteroids, we found that prolonged and medium corticosteroids therapy significantly reduced all-cause mortality (OR = 0.44, 95%CI:0.24-0.82, Z = 2.58, P = 0.01),(RR = 0.35, 95% CI:0.36-0.76, Z = 2.66, P = 0.008). C-reactive protein after three days' therapy significantly reduced (MD = -59.58 mg/L. 95%CI:−88.1~−33.04, P < 0.0001) the risk of septic shock (OR = 0.19, 95% CI0.10-0.36, P < 0.0001) and need for mechanical ventilation(OR = 0.33, 95%CI:0.21-0.52, P < 0.00001).Adjunctive corticosteroids exactly had no influence in gastrointestinal haemorrhage(OR = 0.80, 95%CI:0.23-2.83, P = 0.73) and super infection(OR = 2.62, 95%CI:0.92-7.48, P = 0.07).
Conclusion: 1. Compared with conventional treatment, our results suggested that adjunctive corticosteroids therapy decreased all-cause mortality in patients with severe CAP, and prolonged (5-9 days), medium corticosteroids treatment was more beneficial for severe CAP.
2. The study indicated that corticosteroids treatment was safe. The use of whole-body corticosteroids is not associated with the risk of super infection and upper gastrointestinal bleeding in the patients with severe community acquired pneumonia and reduced the risk of septic shock and the need for mechanical ventilation. Philippine Heart Center, Philippines
Background and Aims: Angiosarcoma of the pulmonary artery is a rare type of malignant vascular tumor characterized by anaplastic cells arising from blood vessels that are rapidly proliferating and extensively infiltrating, hence tends to be aggressive.
Methods:
A 36-year-old female presented as shortness of breath for 6 weeks associated with orthopnea and bipedal edema.
Results: CT Pulmonary Angiogram revealed pulmonary embolism, hence patient was given heparin drip and eventually shifted to factor XA inhibitor and discharged. Persistence of shortness of breath prompted readmission. A review of previous CT Pulmonary Angiogram showed a pulmonary artery mass. Patient underwent pulmonary endarterectomy and excision of the pulmonary artery mass, whose histopathologic findings, revealed pulmonary angiosarcoma.
Conclusion:
The pulmonary artery angiosarcoma often mimicks the presentation of pulmonary embolism and a high index of suspicion is important in order to diagnose and manage this rare and highly aggressive disease. Thoracoscopy or open lung biopsy are the diagnostic methods but definitive diagnosis will involve histopathological and immunohistochemical findings. Management options include surgical resection, radiation, and chemotherapy, however, these tumours have a very poor prognosis. Background and Aims: Post-stroke pneumonia is a complication of stroke with the highest mortality. The proposed pathophysiology of poststroke pneumonia is aspiration due to dysphagia in stroke patients. One way to reduce the risk of post-stroke pneumonia is the use of ACE inhibitor, which stimulate cough reflex to prevent aspiration. In Indonesia, it is not yet known whether the use of ACE inhibitor in stroke patients reduce the risk of post-stroke pneumonia.
Methods: Articles were searched in four electronic databases:
Pubmed, Proquest, EBSCOHost, and Scopus. Articles were selected based on the relevance to the clinical questions and met the inclusion and exclusion criteria. Two selected articles were appraised based on its validity, importance, and applicability, and according to Oxford Center of Evidenced-Based Medicine 2011.
Results: Appraisals were made for two chosen articles; an RCT article and an meta-analysis article. RCT study conducted in 10 countries shows that ACE inhibitor given to stroke patients reduce the risk of poststroke pneumonia. Meta-analysis study reviews four studies from Japan shows that ACE inhibitor given to the patients reduce the risk of poststroke pneumonia. In our patient's case, a 57 years old female has loss of consciousness, right-sided hemiparesis, and aphasia due to stroke. Patient has hypertension for 10 years and has been given captopril, one of ACE inhibitors drugs. After 10 days of treatment in the hospital, there were no sign of pneumonia, such as fever, cough, dyspnea, and rhonki. 
